Clinical Study of Adjuvant Capecitabine Monotherapy in Chinese Elderly Patients (Aged 55–70) with Stage IIa Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|33|8-9|433-436

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.8-9, 2010-07, pp. : 433-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Open-Label, Multicenter Study of Outpatient Capecitabine Monotherapy in 631 Patients with Pretreated Advanced Breast Cancer

By  

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 51-57

Karger

Access to resources Recommend Favorite

A randomized phase 2 study comparing EC or CMF versus nab‐paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high‐risk early breast cancer (ICE II‐GBG 52)

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3639-3648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elderly Breast Cancer Patients: Adjuvant Chemotherapy and Adjuvant Endocrine Therapy

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 45, Iss. 3, 2005-06 ,pp. : 137-142

Karger

Access to resources Recommend Favorite

The evolving role of adjuvant radiotherapy for elderly women with early‐stage breast cancer

By  

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2331-2340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi‐institutional study

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1937-1948

John Wiley & Sons Inc

Access to resources Recommend Favorite